Dr. Thornton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
601 Elmwood Ave
# 320
Rochester, NY 14642Phone+1 585-275-2559Fax+1 585-276-1947- Is this information wrong?
Education & Training
- University of RochesterResidency, Neurology, 1989 - 1991
- Oregon Health & Science UniversityResidency, Neurology, 1982 - 1985
- UCLA-VA Greater Los AngelesInternship, Internal Medicine, 1981 - 1982
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1981
Certifications & Licensure
- OR State Medical License 1983 - Present
- NY State Medical License 1989 - 2025
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry Start of enrollment: 2000 Sep 01
- Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1 Start of enrollment: 2011 Jun 01
- Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Start of enrollment: 2019 Jan 01
Publications & Presentations
PubMed
- Combinatorial chloride and calcium channelopathy in myotonic dystrophy.Lily A Cisco, Matthew T Sipple, Katherine M Edwards, Charles A Thornton, John D Lueck> ;Biorxiv. 2023 Jun 1
- 6 citationsAntisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial.Charles A Thornton, Richard Thomas Moxley 3rd, Katy Eichinger, Chad Heatwole, Laurence Mignon, W David Arnold, Tetsuo Ashizawa, John W Day, Gersham Dent, Matthew K Tan...> ;The Lancet. Neurology. 2023 Mar 1
- 2 citationsRemote assessment of myotonic dystrophy type 1: A feasibility study.Johanna Hamel, Peter D Creigh, Jeanne Dekdebrun, Katy Eichinger, Charles A Thornton> ;Muscle & Nerve. 2022 Sep 1
- Join now to see all
Press Mentions
- Triplet Therapeutics Announces Participation in Natural History Study of Myotonic Dystrophy Type 1August 18th, 2020
- Grant Marks Two Decades of NIH Support for Muscular Dystrophy ResearchFebruary 25th, 2019
- Finding a Treatment for Postoperative Cognitive DysfunctionOctober 4th, 2017
- Join now to see all
Hospital Affiliations
- Highland HospitalRochester, New York
- Rochester General HospitalRochester, New York
- Strong Memorial Hospital of the University of RochesterRochester, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: